$SANA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sana Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sana Biotechnology, Inc.. Get notifications about new insider transactions in Sana Biotechnology, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Apr 27 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | J | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,156,250 | 0 | 10,301,250 | 145 K to 10.3 M (+7,004.31 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,156,250 | 0 | 10,303,750 | 147.5 K to 10.3 M (+6,885.59 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,156,250 | 0 | 10,301,250 | 145 K to 10.3 M (+7,004.31 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | ARCH Venture Fund X, L.P. | 10% Owner | Buy | C | 0.00 | 10,156,250 | 0 | 10,303,750 | 147.5 K to 10.3 M (+6,885.59 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Bishop Hans Edgar | Director | Option Exercise | C | 0.00 | 156,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Bishop Hans Edgar | Director | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Bishop Hans Edgar | Director | Option Exercise | C | 0.00 | 1,075,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Bishop Hans Edgar | Director | Buy | C | 0.00 | 2,031,250 | 0 | 5,736,250 | 3.7 M to 5.7 M (+54.82 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 11,585,199 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 11,441,326 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 9,725,122 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 1,487,371 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 11,585,199 | 0 | 11,585,199 | 0 to 11.6 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 11,441,326 | 0 | 11,441,326 | 0 to 11.4 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 9,725,122 | 0 | 9,725,122 | 0 to 9.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 1,487,371 | 0 | 1,487,371 | 0 to 1.5 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 2,343,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 781,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 9,375,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 5,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | C | 0.00 | 3,687,500 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 11,718,750 | 0 | 11,718,750 | 0 to 11.7 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,156,250 | 0 | 10,301,250 | 145 K to 10.3 M (+7,004.31 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Buy | C | 0.00 | 10,156,250 | 0 | 10,303,750 | 147.5 K to 10.3 M (+6,885.59 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Harr Steve | President & CEO | Option Exercise | C | 0.00 | 156,250 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Harr Steve | President & CEO | Option Exercise | C | 0.00 | 800,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Harr Steve | President & CEO | Option Exercise | C | 0.00 | 1,075,000 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | Harr Steve | President & CEO | Buy | C | 0.00 | 2,031,250 | 0 | 8,173,750 | 6.1 M to 8.2 M (+33.07 %) |
| Feb 10 2021 | SANA | Sana Biotechnology ... | von Maltzahn Geoffrey | Director | Option Exercise | C | 0.00 | 366,122 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | von Maltzahn Geoffrey | Director | Option Exercise | C | 0.00 | 1,464,488 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | von Maltzahn Geoffrey | Director | Buy | C | 0.00 | 366,122 | 0 | 366,122 | 0 to 366.1 K |
| Feb 10 2021 | SANA | Sana Biotechnology ... | von Maltzahn Geoffrey | Director | Buy | C | 0.00 | 1,464,488 | 0 | 1,464,488 | 0 to 1.5 M |
| Feb 10 2021 | SANA | Sana Biotechnology ... | MacDonald James J. | See Remarks | Option Exercise | C | 0.00 | 7,812 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | MacDonald James J. | See Remarks | Option Exercise | C | 0.00 | 93,750 | 0 | 0 | |
| Feb 10 2021 | SANA | Sana Biotechnology ... | MacDonald James J. | See Remarks | Buy | C | 0.00 | 7,812 | 0 | 7,812 | 0 to 7.8 K |
| Feb 10 2021 | SANA | Sana Biotechnology ... | MacDonald James J. | See Remarks | Buy | C | 0.00 | 93,750 | 0 | 428,750 | 335 K to 428.8 K (+27.99 %) |
| Feb 05 2021 | SANA | Sana Biotechnology ... | NELSEN ROBERT | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | von Maltzahn Geoffrey | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Bishop Hans Edgar | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | AGARWAL SUNIL | See Remarks | Option Exercise | A | 25.00 | 48,000 | 1,200,000 | 48,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Bilenker Joshua H. | Director | Option Exercise | A | 25.00 | 7,000 | 175,000 | 7,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Cole Douglas G. | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Wilderotter Mary Agnes | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
| Feb 05 2021 | SANA | Sana Biotechnology ... | Seitz Michelle | Director | Option Exercise | A | 25.00 | 7,000 | 175,000 | 7,000 |
Page: 1